{"schema_version":"secwatch.filing_event.v1","accession":"0001932393-24-000012","form_type":"8-K","ticker":"GEHC","cik":"0001932393","company_name":"GE HealthCare Technologies Inc.","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.332000+00:00","generated_at":"2026-06-06T08:36:16.147211+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GE HealthCare Q4 revenue $5.2B (+5% organic); Adj EPS $1.18; guides FY2024 Adj EPS $4.20-4.35","bullets":["Q4 revenue $5.2B (+5% organic); net income $403M vs $554M; Adj EBIT margin 16.1% vs 17.1%.","FY 2023 revenue $19.6B (+8% organic); net income $1.6B; Adj EPS $3.93 vs $4.63 prior year.","Free cash flow Q4 $956M; repaid $850M debt in Q4 and $150M in Jan 2024.","FY2024 guidance: organic rev ~4% growth, Adj EBIT margin 15.6-15.9%, Adj EPS $4.20-4.35, FCF ~$1.8B.","Segment: Imaging +4% organic, Ultrasound -2%, Patient Care +4%, Pharma Diagnostics +23%."],"urls":{"canonical":"https://secwatch.observer/filing/0001932393-24-000012","json":"https://secwatch.observer/filing/0001932393-24-000012.json","markdown":"https://secwatch.observer/filing/0001932393-24-000012.md","text":"https://secwatch.observer/filing/0001932393-24-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000012/0001932393-24-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000012/gehc-20240206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T08:36:16.147211+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"801af18a9952ce6b2a53ef5f67f35c27052db727","claim":"GE HealthCare Technologies Inc. reported financial results for the fourth quarter and fiscal year ended December 31, 2023.","evidence_excerpt":"On February 6, 2024 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its fourth quarter and fiscal year ended December 31, 2023 financial results.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000012/0001932393-24-000012-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and fiscal year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}